# Abemaciclib and Letrozole to Treat Endometrial Cancer

> **NCT04393285** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Gynecologic Oncology Group** · enrollment: 53 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Abemaciclib
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT04393285
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-10
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04393285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04393285, "Abemaciclib and Letrozole to Treat Endometrial Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04393285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*